Center for Research in Security Prices, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma

First Posted Date
2021-09-10
Last Posted Date
2024-01-03
Lead Sponsor
University of Chicago
Target Recruit Count
2
Registration Number
NCT05041062
Locations
🇺🇸

The University of Chicago, Chicago, Illinois, United States

Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

First Posted Date
2021-08-25
Last Posted Date
2024-11-12
Lead Sponsor
University of Chicago
Target Recruit Count
30
Registration Number
NCT05019976
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Brain Function and EEG

Early Phase 1
Completed
Conditions
Healthy
Mood
Interventions
Drug: Methamphetamine
Drug: Placebo
First Posted Date
2021-08-12
Last Posted Date
2024-01-24
Lead Sponsor
University of Chicago
Target Recruit Count
40
Registration Number
NCT05003076
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Epidiolex in Obsessive Compulsive Disorder and Related Disorders

First Posted Date
2021-07-27
Last Posted Date
2024-07-25
Lead Sponsor
University of Chicago
Target Recruit Count
15
Registration Number
NCT04978428
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Family Supports and Beliefs Survey

First Posted Date
2021-07-21
Last Posted Date
2022-09-22
Lead Sponsor
University of Chicago
Target Recruit Count
205
Registration Number
NCT04971265
Locations
🇺🇸

TMW Center for Early Learning + Public Health at the University of Chicago Medicine, Chicago, Illinois, United States

My Diabetes, My Community

First Posted Date
2021-07-21
Last Posted Date
2024-11-06
Lead Sponsor
University of Chicago
Target Recruit Count
505
Registration Number
NCT04970810
Locations
🇺🇸

University of Chicago Medicine, Chicago, Illinois, United States

A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms

First Posted Date
2021-07-09
Last Posted Date
2024-07-31
Lead Sponsor
University of Chicago
Registration Number
NCT04955938
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients

First Posted Date
2021-07-08
Last Posted Date
2022-11-16
Lead Sponsor
University of Chicago
Target Recruit Count
80
Registration Number
NCT04954157
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

First Posted Date
2021-07-01
Last Posted Date
2024-08-01
Lead Sponsor
University of Chicago
Target Recruit Count
60
Registration Number
NCT04948203
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

Turning Dexmedetomidine Into a Powerful Anesthetic That Can be Rapidly and Completely Reversed

First Posted Date
2021-06-28
Last Posted Date
2023-05-17
Lead Sponsor
University of Chicago
Registration Number
NCT04942340
Locations
🇺🇸

University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy